Fundraising FoxDepartment of Health and Human Services — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Ambergenambergen.cominApr 2022 · $2M
AmberGen operates the MaxOmic Laboratory, offering multiomic spatial biology imaging and analysis services along with probes, panels, and antibody conjugation kits based on its patented photocleavable mass-tag technology.
BiotechDeep TechHealthtechWatertown, US
Kenneth Rothschild(Executive Officer, Director)inMichael Easterling(Director)John Gillespie(Executive Officer, Director)Peter Finn(Executive Officer)Brian Rothschild(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.